First National Trust Co Has $715,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

First National Trust Co decreased its stake in CVS Health Co. (NYSE:CVS) by 28.2% in the third quarter, HoldingsChannel reports. The firm owned 11,375 shares of the pharmacy operator’s stock after selling 4,466 shares during the period. First National Trust Co’s holdings in CVS Health were worth $715,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CVS. GSA Capital Partners LLP acquired a new stake in shares of CVS Health during the third quarter valued at approximately $816,000. Apollon Wealth Management LLC raised its stake in CVS Health by 5.0% during the 3rd quarter. Apollon Wealth Management LLC now owns 33,635 shares of the pharmacy operator’s stock valued at $2,115,000 after purchasing an additional 1,608 shares during the period. Versor Investments LP purchased a new stake in shares of CVS Health in the third quarter valued at $371,000. Delta Financial Advisors LLC boosted its position in shares of CVS Health by 13.2% in the third quarter. Delta Financial Advisors LLC now owns 35,096 shares of the pharmacy operator’s stock worth $2,207,000 after buying an additional 4,080 shares during the period. Finally, Addison Advisors LLC grew its holdings in shares of CVS Health by 187.8% during the third quarter. Addison Advisors LLC now owns 7,815 shares of the pharmacy operator’s stock valued at $491,000 after buying an additional 5,100 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on CVS shares. Evercore ISI raised their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Mizuho lowered their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Wells Fargo & Company cut their target price on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a research report on Monday, November 4th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Finally, UBS Group raised their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Nine equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $73.00.

CVS Health Trading Down 3.2 %

CVS Health stock opened at $54.04 on Wednesday. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock has a market cap of $68.00 billion, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 0.97 and a beta of 0.55. The business has a 50 day moving average price of $59.53 and a two-hundred day moving average price of $58.97. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.21 EPS. As a group, equities analysts forecast that CVS Health Co. will post 5.44 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.92%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.